Skip to main content
. 2023 Aug 28;10(30):2303006. doi: 10.1002/advs.202303006

Figure 7.

Figure 7

Evaluation of Lap@C‐C adjuvanted DC vaccine against hepatitis B virus (HBV). a) Construction schedule of visualized HBV clearance mouse model. b, c) Representative images and statistical analysis of fluorescence intensity in the mouse liver after hydrodynamic injection of pGL3/Fluc‐HBV1.2. d, e) Assay of serum HBV DNA copy number and hepatitis B surface antigen (HBsAg) titers. f) Serum alanine aminotransferase activity in mice. g) Infiltration of CD8+ T cells into the liver detected by immunohistochemical staining. Data represent mean ± SD (n = 5). *P < 0.05 DCLap@C‐C group compared with the DCNaïve group. #P < 0.05 DCLap@C‐C group compared with the DCC‐C group. Representative results from two or three replicates are shown.